2019 ​Psychostimulant Symposium

The Pennsylvania Department of Drug and Alcohol Programs (DDAP), in coordination with the Mid-Atlantic High-Intensity Drug Trafficking Area (HIDTA) program, which is funded by the Office of National Drug Control Policy (ONDCP), convened the Pennsylvania Psychostimulant Symposium on November 19, 2019, at the Best Western Premier in Harrisburg. Check out photos and videoOpens In A New Window from the 2019 symposium.

More than 300 participants learned the dangers associated with the misuse of psychostimulants while discovering collaborative strategies for protecting communities and preventing widespread stimulant use disorder. Below are slides from the following plenary session presentations:

• Emerging Threat Report
  John L. Eadie, Public Health and Prescription Drug Monitoring Projects Coordinator
  National Emerging Threats Initiative (NETI)
  A National High-Intensity Drug Trafficking Area (HIDTA) Program

• Assessment and Treatment of Methamphetamine Use
  Margaret Jarvis, MD DFASAM
  Chief, Addiction Medicine
  Department of Psychiatry
  Geisinger Health System
  

• Health and Safety Consequences of Psychostimulant Use
  Michael Lynch, MD
  Medical Director, Pittsburgh Poison Center
  Assistant Professor of Emergency Medicine, Toxicology, and Pediatrics
  University of Pittsburgh